GB201602486D0 - Anti-inflammatory formulation - Google Patents

Anti-inflammatory formulation

Info

Publication number
GB201602486D0
GB201602486D0 GBGB1602486.1A GB201602486A GB201602486D0 GB 201602486 D0 GB201602486 D0 GB 201602486D0 GB 201602486 A GB201602486 A GB 201602486A GB 201602486 D0 GB201602486 D0 GB 201602486D0
Authority
GB
United Kingdom
Prior art keywords
inflammatory formulation
inflammatory
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1602486.1A
Other versions
GB2547241A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akl Res & Dev Ltd
Original Assignee
Akl Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akl Res & Dev Ltd filed Critical Akl Res & Dev Ltd
Priority to GB1602486.1A priority Critical patent/GB2547241A/en
Publication of GB201602486D0 publication Critical patent/GB201602486D0/en
Priority to PCT/GB2017/050352 priority patent/WO2017137767A1/en
Publication of GB2547241A publication Critical patent/GB2547241A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1602486.1A 2016-02-11 2016-02-11 Anti-inflammatory formulation Withdrawn GB2547241A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1602486.1A GB2547241A (en) 2016-02-11 2016-02-11 Anti-inflammatory formulation
PCT/GB2017/050352 WO2017137767A1 (en) 2016-02-11 2017-02-10 Anti-neurodegenerative disease formulation containing apocynin and paeonol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1602486.1A GB2547241A (en) 2016-02-11 2016-02-11 Anti-inflammatory formulation

Publications (2)

Publication Number Publication Date
GB201602486D0 true GB201602486D0 (en) 2016-03-30
GB2547241A GB2547241A (en) 2017-08-16

Family

ID=55697574

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1602486.1A Withdrawn GB2547241A (en) 2016-02-11 2016-02-11 Anti-inflammatory formulation

Country Status (2)

Country Link
GB (1) GB2547241A (en)
WO (1) WO2017137767A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2568698A (en) * 2017-11-23 2019-05-29 Akl Res & Development Ltd Formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003201255A (en) * 2001-11-05 2003-07-18 Otsuka Pharmaceut Factory Inc Prophylactic and therapeutic agent for alzheimer's disease
GB2424833B (en) * 2005-04-08 2008-12-10 Nicholas John Larkins Anti-inflammatory formulation comprising apocyanin and paeonol
US20060269494A1 (en) * 2005-05-27 2006-11-30 Gupta Shyam K New Ubiquitin-Proteasome Regulating Compounds and Their Application in Cosmetic and Pharmaceutical Formulations
CN101143181B (en) * 2006-09-12 2010-11-03 广州中医药大学第二附属医院 Traditional Chinese medicinal composition for treating senile dementia and preparation method and application thereof
CN101461550B (en) * 2008-03-28 2012-07-25 牛建伟 Spirulina tablet for student and preparation method thereof
US20130338199A1 (en) * 2008-07-11 2013-12-19 Uday Saxena Novel Niacin Compositions for Reduction of Amyloid Beta Peptide 42 (AB42) Production and for Treatment of Alzheimer's Disease
GB2463080A (en) * 2008-09-02 2010-03-03 Nicholas John Larkins Pharmaceutical preparation
GB201115757D0 (en) * 2011-09-12 2011-10-26 Akl Inflammatory Ltd Formulation for the treatment of benign prostate hyperplasia
CA2856217C (en) * 2011-11-15 2020-02-18 Tarek M. Saleh Apocynin-lipoic acid conjugates and uses thereof
KR101528190B1 (en) * 2013-08-27 2015-06-12 영남대학교 산학협력단 Composition for inhibiting cellular senescence comprising 2,5-dihydroxy-4-methoxyacetophenone isolated from Paeonia suffruticosa
KR101523841B1 (en) * 2013-09-05 2015-05-28 건국대학교 산학협력단 Composition for treatment or prevention of Vascular Dementia comprising an inhibitor of NADPH oxidase 1 as an active ingredient

Also Published As

Publication number Publication date
GB2547241A (en) 2017-08-16
WO2017137767A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
HK1256195A1 (en) Stable anti-ifnar1 formulation
GB2551985B (en) Novel formulation
EP3192518A4 (en) Anti-inflammatory agent
IL274139A (en) Aerosolisable formulation
PT3426294T (en) Pharmaceutical formulation
GB201514758D0 (en) Formulation
IL274719A (en) Formulation
IL266537A (en) Pharmaceutical formulation
GB201608356D0 (en) Formulation
ZA201807851B (en) Pharmaceutical formulation
GB201713724D0 (en) Formulation
GB201706969D0 (en) Formulation
RS62057B1 (en) Maropitant formulation
GB201521771D0 (en) Formulation
GB201511255D0 (en) Formulation
GB201509891D0 (en) Formulation
GB201602486D0 (en) Anti-inflammatory formulation
GB201707615D0 (en) Formulation
PL3559185T3 (en) Clear-rinse formulation
GB2568045B (en) Formulation
GB201720808D0 (en) Formulation
GB201719464D0 (en) Formulation
GB201609925D0 (en) Formulation
GB201702058D0 (en) Formulation
GB201700257D0 (en) New formulation

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)